Enter your login e-mail to the account
Search
- Monoclonal antibodies in the treatment of chronic lymphocytic leukemia
MUDr. Eva Mikušková, MUDr. Ľudmila Demitrovičová, MUDr. Juraj Chudej, PhD.
(6/2014, Oncohematology Review ) - New Therapeutic Opportunities in Chronic Lymphocytic Leukemia
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Matej Hrnčár
(6/2014, Oncohematology Review ) - Treatment of multiple myeloma
MUDr. Emília Flochová, PhD., MUDr. Lucia Stančiaková
(5/2016, Spectrum ) - Waldenström’s macroglobulinemia in 2016: in order to optimize immunochemotherapy minimizing side effects
MUDr. Michal Kaščák, Mgr. Zuzaná Kufová, Mgr. Kateřina Growková, prof. MUDr. Roman Hájek, CSc.
(5/2016, Spectrum ) - Current possibilities of treatment of chronic B-lymphocytic leukemia in Slovakia and world
Prof. MUDr. Mikuláš Hrubiško, CSc.
(1/2022, Review articles ) - SPRÁVA ZO 49. MÍTINGU AMERICKEJ HEMATOLOGICKEJ SPOLOČNOSTI (ASH) V ATLANTE
MUDr. Andrej Vranovský
(2/2008, Events ) - Zaujímavosti z literatúry
doc. MUDr. Peter Beržinec, CSc.
(1/2009, Information & comments ) - Lymfómové fórum 2010
MUDr. Miriam Ladická
(2/2010, Events ) - Cancer Drugs Fund – starting point or final solution to pay for innovative oncology treatment?
MUDr. Pavol Adamkov, Ing. Petra Szilágyiová, Mgr. Tomáš Pastorek
(1/2014, Main topic ) - Treatment of relapsed and refractory myeloma
MUDr. Alexander Wild
(4/2013, Focus ) - Waldenström‘s macroglobulinemia and treatment
MUDr. Radoslav Greksák, PhD.
(1/2019, Review articles ) - Kritériá minimálnej reziduálnej choroby pri chronickej lymfocytovej leukémii
MUDr. Juliana Holasová, MUDr. Alexander Wild, RNDr. Soňa Ölvecká, Mgr. Mariana Jacková
(2/2018, Review articles ) - Lymfómové fórum – správa z podujatia
MUDr. Andrej Vranovský
(2/2009, Events ) - Treatment of indolent B-cell lymphomas
MUDr. Veronika Ballová
(2/2014, Main topic ) - Správa z ASH
MUDr. Andrej Vranovský, PhD.
(2/2014, Events ) - Initial treatment of chronic lymphocytic leukaemia
MUDr. Emília Flochová, PhD.
(5/2014, Oncohematology Review ) - DID THE INTRODUCTION OF TARGETED THERAPY LIMIT THE IMPORTANCE OF CYTOSTATIC TREATMENT ?
prof. MUDr. Pavel Klener, DrSc.
(6/2007, Review articles ) - Treatment of relapse and refractory chronic lymphocytic leukemia
MUDr. Natália Štecová
(5/2014, Oncohematology Review ) - Suplement - Stratégia liečby malígnych lymfómov
(1/2018, online attachment ) - Prognostické faktory pri chronickej lymfocytovej leukémii
MUDr. Ľudmila Demitrovičová, PhD.
(4/2018, Review articles )